PolyNovo Limited
ASX:PNV
$ 2.24
$-0.02 (-0.88%)
$ 2.24
$-0.02 (-0.88%)
End-of-day quote: 05/10/2024

PNV: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
ASX:CSL
CSL
279.18 22.87% 43.8% 134,914.5 1.29% 7.18%
ASX:TLX
Telix Pharmaceuticals
15.49 0% 0% 5,072.5 0% 0%
ASX:NEU
Neuren Pharmaceuticals
19.09 -85.21% -76.08% 2,451.76 0% 76.53%
ASX:CUV
Clinuvel Pharmaceuticals
15.21 199.2% 245.44% 754.06 0.34% 16.92%
ASX:IMU
Imugene
0.08 0% 0% 636.82 0% 0%
ASX:IMM
Immutep
0.46 0% 0% 558.75 0% 0%
ASX:MSB
Mesoblast
1.07 0% 0% 299.37 0% 0%
ASX:PYC
PYC Therapeutics
0.10 0% 0% 294.9 0% 0%
ASX:CGS
Cogstate
1.28 -89.21% -85.11% 239.09 0% -33.33%
ASX:BOT
Botanix Pharmaceuticals
0.19 0% 0% 222.78 0% 0%
ASX:DXB
Dimerix
0.33 0% 0% 159.38 0% 0%
ASX:ACW
Actinogen Medical
0.03 0% 0% 69.94 0% 0%
ASX:BIT
Biotron
0.06 0% 0% 65.87 0% 0%
ASX:SPL
Starpharma Holdings
0.12 0% 0% 51.51 0% 0%
ASX:IVX
Invion
0.01 0% 0% 44.95 0% 0%
ASX:CYP
Cynata Therapeutics
0.23 0% 0% 42.21 0% 0%
ASX:PTX
Prescient Therapeutics
0.04 0% 0% 40.27 0% 0%
ASX:1AI
Algorae Pharmaceuticals
0.01 0% 0% 21.6 0% 0%
ASX:IMC
Immuron
0.07 0% 0% 18.22 0% 0%
ASX:ATH
Alterity Therapeutics
0.00 0% 0% 17.53 0% 0%